Medicine Related News
World’s first magic mushroom nasal spray for PTSD and depression
PTSD and depression are two conditions that are being trialled for treatment with psilocybin.
A ‘magic mushroom’ nasal spray has been designed to make microdosing...
Breakthrough epigenomic technology can help to combat disease
Much remains unknown about diseases and the way our bodies respond to them, in part because the human genome is the complete DNA assembly...
NIH study finds anti-seizure drugs equally effective
New findings reveal that three anti-seizure drugs, levetiracetam, fosphenytoin, and valproate, are equally safe and effective in treating patients with this condition.
These three anti-seizure...
Why veterinarians should be at the heart of the drug resistance fightback
When antibiotic resistance could be responsible for up to 10 million deaths a year by 2050 if left unchecked, it is natural to want...
General Election manifesto for UK pharmaceutical industry launched
The Association of the British Pharmaceutical Industry has launched its General Election 2020 Manifesto for Medicine.
The UK pharmaceutical industry body is calling on all...
First CBD oil to be approved by the European Medicines Agency
A GW Pharmaceuticals Cannabidiol oral solution, EPIDYOLEX®, is the first plant-derived cannabis-based medicine to be approved by the European Medicines Agency (EMA).
EPIDYOLEX® cannabidiol oral...
Growth hormone derivative shows promise for children with deficiency
A novel growth hormone derivative that is now in development has demonstrated promise for children with growth hormone deficiency.
The derivative was tested in Phase...
New Frontier Data – trusted cannabis industry research
New Frontier Data was founded in 2014 with the mission of collating and analysing data on the burgeoning cannabis industry.
Today the company operates across...
Platome Biotechnology – advancing cellular therapies
Icelandic company Platome Biotechnology is reinventing cell culture to help speed up the development of approved cellular therapies.
Regenerative medicine will play a key role...
EMA responds to liver injury concerns over uterine fibroids medicine
The European Medicines Agency (EMA) has responded to concerns that Esmya (ulipristal acetate), a uterine fibroids medicine, presents a risk of serious liver injury.
Having...
Ethical animal testing and drug development at CABMM
The Competence Center for Applied Biotechnology and Molecular Medicine (CABMM) is an innovative, cutting-edge medical research organisation at the University of Zurich, Switzerland, which brings...